Search clinical trials for: Lansoprazole (Prevacid)

Total 472 results

University of Western Ontario, Canada

Completed

Evaluation of Methods for the Determination of Chromogranin A in Routine Blood Samples

Neuroendocrine Carcinoma (Carcinoid)

Canada
Charles Mel Wilcox, MD
Takeda Pharmaceuticals North America, Inc.

Completed

Treatment of Zollinger-Ellison Syndrome With Prevacid

Zollinger-Ellison Syndrome | Multiple Endocrine Neoplasia
Emory University

Unknown

A Randomized, Double-Blind, Placebo-Controlled Study of Gastroesophageal Reflux Disease Therapy.

Asthma

United States
University of Utah

Terminated

Elucidation of Acid-Induced Pulmonary Inflammation

Asthma | Gastroesophageal Reflux

United States
AstraZeneca

Completed

A Randomized, Open-Label, Comparative 3-Way Treatment Crossover Study of 24-Hour Intragastric pH Profile of Once Daily Oral Administration of Esomeprazole 40mg, Lansoprazole 30mg, and Pantoprazole 40mg at Steady State in NSAID-Using Patients

Nausea | Heartburn | Acid Regurgitation | Upper Abdominal Pain
M.D. Anderson Cancer Center
TAP Pharmaceutical Products Inc.

Withdrawn

Reflux Disease in Head and Neck Cancer Patients Undergoing Radiation Therapy

Head and Neck Cancer | Gastroesophageal Reflux Disease | Oropharyngeal Cancer
Vanderbilt University
TAP Pharmaceutical Products Inc.

Completed

Efficacy of Lansoprazole in Chronic Post Nasal Drip (PND)

Larynx Disease

United States
National Taiwan University Hospital

Unknown

Oral Versus IV Proton Pump Inhibitor in High-risk Bleeding Peptic Ulcers After Endoscopic Hemostasis

Peptic Ulcers

Taiwan
Teva Pharmaceuticals USA

Completed

Lansoprazole 30 mg DR Capsule Replicate Food Study

Healthy

United States
Teva Pharmaceuticals USA

Completed

Lansoprazole 30 mg DR Capsule Fasting Replicate Sprinkle Study

Healthy

United States
Takeda

Completed

Efficacy and Safety of Oral Once-Daily Vonoprazan (TAK-438) in Participants With Erosive Esophagitis

Erosive Esophagitis

China, Taiwan, Korea, Republic of, Malaysia
Washington University School of Medicine
TAP Pharmaceutical Products Inc.; Doris Duke Charitable Foundation

Completed

A Clinical Trial of Proton Pump Inhibitors to Treat Children With Chronic Otitis Media With Effusion

Otitis Media With Effusion

United States
Vanderbilt University Medical Center

Completed

Do Laryngeal Tissue Changes in Patients Suspected of Having Laryngopharyngeal Reflux Predict Response to Treatment?

Gastroesophageal Reflux | Larynx Disease

United States
Teva Pharmaceuticals USA

Completed

Lansoprazole 30 mg DR Capsule Fasting Study

Healthy

United States
Takeda

Completed

Efficacy and Safety of Vonoprazan Compared to Lansoprazole in the Maintenance Treatment of Erosive Esophagitis

Erosive Esophagitis

China, Taiwan, Korea, Republic of, Malaysia
University of California, Davis

Completed

Twice Daily Prevacid for the Treatment of Laryngopharyngeal Reflux

Laryngopharyngeal Reflux

United States
Southwest Oncology Group
Bill and Melinda Gates Foundation

Completed

S0701, Trial of Three Antibiotic Regimens to Eradicate Helicobacter Pylori (H. Pylori)

Helicobacter Pylori Infection

Chile, Colombia, Costa Rica, Honduras, Mexico, Nicaragua
Head and Neck Surgery Associates

Completed

Investigation of the Association Between Nasal Polyposis and Extraesophageal Reflux Disease

Gastroesophageal Reflux | Nasal Polyps

United States
University of Kansas Medical Center
TAP Pharmaceutical Products Inc.

Terminated

Dietary Control Alone Versus Dietary Control Plus Use of Proton Pump Inhibitors to Treat Pediatric Hoarseness

Dysphonia

United States
AstraZeneca

Completed

Evaluation of 24-Hour Intragastric pH Using Esomeprazole, Lansoprazole, and Pantoprazole in Hispanic Patients With GERD

Gastroesophageal Reflux Disease

United States, Puerto Rico
Emory University
TAP Pharmaceutical Products Inc.

Completed

Effect of Prevacid on Prostaglandin Levels in Patient With Stress Ulcer

Stomach Ulcer

United States
Dr. Reddy's Laboratories Limited

Completed

Bioequivalence Study of Lansoprazole DR Capsules 30 mg in Fasting Conditions

Healthy

India
Boston Children's Hospital

Terminated

The Effects of Reducing Stomach Acid on Post-tonsillectomy Pain

Post-tonsillectomy Pain | Post-tonsillectomy Activity | Post-tonsillectomy Hydration

United States
Hamilton Health Sciences Corporation
McMaster University

Completed

Study of Anti-reflux Medication as a Potential Treatment for Glue Ear in Children

Otitis Media With Effusion

Canada
LCMC Health

Terminated

Confocal Endomicroscopy for Non-Erosive Reflux Disease Detection (CENERDD)

Gastroesophageal Reflux | Non-erosive Reflux Disease

United States
AstraZeneca

Completed

Study of 24-hour Intragastric pH Profiles of Esomeprazole 40 mg and Lansoprazole 30 mg in Healthy Volunteer Subjects

Healthy

United States
Asan Medical Center

Completed

Helicobacter Pylori and Proton Pump Inhibitor

Helicobacter Infections

Korea, Republic of
Bayer

Completed

Study to Compare Gastric Inhibition of Two Proton Pump Inhibitors (CL2008-18)(P07815)(COMPLETED)

Human Experimentation
Stanford University

Completed

Effect of Proton Pump Inhibitors on Endothelial Function (PPI)

Endothelial Dysfunction

United States
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Study Evaluating The Potential Effect Of Lansoprazole On The Pharmacokinetics Of Bosutinib In Healthy Subjects

Healthy

United States
AstraZeneca

Completed

A Multicenter, Randomized, Double Blind, Double Dummy, Parallel-Group Efficacy Study Comparing 8 Weeks of Treatment With Esomeprazole Magnesium (40mg qd) to Lansoprazole (30mg qd) for the Healing of Erosive Esophagitis in Patients With Moderate or Severe Erosive Esophagitis

Erosive Esophagitis
AstraZeneca

Completed

Multicenter, Randomized, Double-Blind, Double-Dummy, Parallel-Group Comparison of the Remission Rates of Once Daily Treatment With Esomeprazole 20mg and Lansoprazole 15mg for 6 Months in Patients Whose EE Has Been Healed

Erosive Esophagitis
Meridian Bioscience, Inc.
Rabin Medical Center

Completed

13-C Urea Breath Test Using BreathID System and PPIs (Proton Pump Inhibitors)

Helicobacter Pylori Infection

Israel
Novartis

Completed

Efficacy/Safety of Lansoprazole in Patients With Frequent Nighttime Heartburn

Frequent Heartburn

United States
AstraZeneca

Completed

Study Comparing Esomeprazole Magnesium 40mg Once Daily Versus Lansoprazole 30 mg Twice Daily in Symptom Control of Subjects With Persistent Gastrooesophageal Reflux Disease (GERD)

Gastroesophageal Reflux Disease | Heartburn
Takeda

Completed

Efficacy and Safety of Dexlansoprazole MR and Lansoprazole on Healing of Erosive Esophagitis

Esophagitis, Peptic | Esophagitis, Reflux

United States, Poland, Bulgaria, India, South Africa, Canada, Peru, New Zealand, Australia, Lithuania, Slovakia, Hungary, Latvia, Germany, Czech Republic
Procter and Gamble

Completed

Comparison of Prilosec Over-the-counter (OTC)® Versus Prevacid® for Gastric Acid Suppression

Healthy

United States
Takeda

Completed

Safety and Efficacy of Lansoprazole in Patients With Reflux Disease

Gastroesophageal Reflux
Mahidol University
Ramathibodi Hospital

Completed

Helicobacter Pylori Infection in Children With Chronic Idiopathic Thrombocytopenic Purpura

Chronic Idiopathic Thrombocytopenic Purpura | Helicobacter Pylori Infection

Thailand
Takeda

Completed

Efficacy and Safety of Dexlansoprazole MR and Lansoprazole on Healing of Erosive Esophagitis

Esophagitis, Peptic | Esophagitis, Reflux

United States, Poland, Bulgaria, India, Canada, Peru, Russian Federation, Australia, New Zealand, Czech Republic, Slovakia, South Africa, Latvia, Lithuania, Colombia, Germany
IBSA Institut Biochimique SA

Completed

Levothyroxine Sodium in Thyroidectomized Patients Taking Proton Pump Inhibitors

Hypothyroidism;Postablative

United States
Takeda

Completed

Comparison of TAK-438 (Vonoprazan) to Lansoprazole in the Treatment of Gastric Ulcer Participants With or Without Helicobacter Pylori Infection

Gastric Ulcer

Taiwan, China, Korea, Republic of, Philippines
Sanford Health
Juvenile Diabetes Research Foundation

Completed

Combination Therapy With Sitagliptin and Lansoprazole to Restore Pancreatic Beta Cell Function in Recent-Onset Type 1 Diabetes (REPAIR-T1D)

Type 1 Diabetes

United States
Takeda

Completed

Comparison of TAK-438 (Vonoprazan) to Lansoprazole in the Treatment of Duodenal Ulcer Participants With or Without Helicobacter Pylori Infection

Duodenal Ulcer

Taiwan, China, Korea, Republic of, Philippines
University of Rochester
Takeda Pharmaceuticals North America, Inc.

Terminated

Effect of Antireflux Therapy on the Expression of Genes in Patients With GERD

Gastroesophageal Reflux | GERD

United States
West China Hospital

Not yet recruiting

Efficacy of Proton Pump Inhibitors in Cirrhotic Patients With Acute Variceal Bleeding

Upper Gastrointestinal Hemorrhage
Ranjan Dohil
Meritage Pharma, Inc.

Completed

Use of Topical Budesonide in the Treatment of Eosinophilic Esophagitis

Eosinophilic Esophagitis

United States
Janssen Research & Development, LLC

Terminated

Study to Assess the Relative Bioavailability of Fixed-Dose Combination (FDC) Tablet (Simeprevir, Odalasvir and AL-335) Compared With Single Agents Administered Together, and to Assess the Effect of Multiple-Dose Lansoprazole or Omeprazole on Single-Dose Pharmacokinetics of SMV, ODV, and AL-335 (FDC)

Healthy

United States
Johns Hopkins University
National Heart, Lung, and Blood Institute (NHLBI); American Lung Association...

Completed

Lansoprazole to Treat Children With Asthma (SARCA)

Asthma

United States
Takeda

Terminated

A Safety and Efficacy Study of Lansoprazole in Preventing Aspirin-Induced Gastric and Duodenal Ulcers

Duodenal Ulcer | Stomach Ulcer

Japan

3

Subscribe